Used as an intermediate in the synthesis of antifolate agents, particularly in the development of targeted cancer therapies. It plays a role in the preparation of folate receptor-targeted drugs and prodrugs designed to deliver cytotoxic agents selectively to tumor cells. Its structure allows conjugation to active pharmaceutical ingredients for enhanced specificity and reduced systemic toxicity. Commonly employed in research settings for developing novel chemotherapeutics and diagnostic agents.